Advertisement

Topics

Orion cortical visual prosthesis system gets FDA expedited access pathway designation

13:30 EST 8 Nov 2017 | Healio

The FDA has granted expedited access pathway designation to Second Sight Medical Products for its Orion cortical visual prosthesis system, according to a company press release.
The designation, given to select medical devices, is intended to help patients have more timely access to devices by expediting their development, assessment and review, the release said.
“These advantages potentially allow the FDA to approve Orion with fewer patients and with a shorter follow-up timeline, thus facilitating a faster entry of Orion into the commercial market,” Will McGuire, president and CEO

Original Article: Orion cortical visual prosthesis system gets FDA expedited access pathway designation

NEXT ARTICLE

More From BioPortfolio on "Orion cortical visual prosthesis system gets FDA expedited access pathway designation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Arthroplasty
Arthroplasty is a surgical procedure to restore the integrity and function of a joint. A joint can be restored by resurfacing the bones. An artificial joint (called a prosthesis) may also be used. Various types of arthritis may affect the joints. Osteo...